PT1210943E - Nova utilizacao para budesonida e formoterol - Google Patents

Nova utilizacao para budesonida e formoterol

Info

Publication number
PT1210943E
PT1210943E PT02001670T PT02001670T PT1210943E PT 1210943 E PT1210943 E PT 1210943E PT 02001670 T PT02001670 T PT 02001670T PT 02001670 T PT02001670 T PT 02001670T PT 1210943 E PT1210943 E PT 1210943E
Authority
PT
Portugal
Prior art keywords
formoterol
budesonide
new used
new
relates
Prior art date
Application number
PT02001670T
Other languages
English (en)
Portuguese (pt)
Inventor
Carl-Axel Bauer
Jan Trofast
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20408325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1210943(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PT1210943E publication Critical patent/PT1210943E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT02001670T 1997-09-19 1998-09-09 Nova utilizacao para budesonida e formoterol PT1210943E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9703407A SE9703407D0 (sv) 1997-09-19 1997-09-19 New use

Publications (1)

Publication Number Publication Date
PT1210943E true PT1210943E (pt) 2006-09-29

Family

ID=20408325

Family Applications (2)

Application Number Title Priority Date Filing Date
PT02001670T PT1210943E (pt) 1997-09-19 1998-09-09 Nova utilizacao para budesonida e formoterol
PT98944373T PT1014993E (pt) 1997-09-19 1998-09-09 Nova utilizacao de budenosido e formoterol

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT98944373T PT1014993E (pt) 1997-09-19 1998-09-09 Nova utilizacao de budenosido e formoterol

Country Status (38)

Country Link
US (2) US7897646B2 (OSRAM)
EP (2) EP1014993B1 (OSRAM)
JP (1) JP2001517630A (OSRAM)
KR (1) KR20010024140A (OSRAM)
CN (1) CN1149998C (OSRAM)
AR (1) AR013506A1 (OSRAM)
AT (2) ATE222106T1 (OSRAM)
AU (1) AU757235B2 (OSRAM)
BR (1) BR9812325A (OSRAM)
CA (1) CA2302700C (OSRAM)
CY (1) CY1106156T1 (OSRAM)
CZ (1) CZ295250B6 (OSRAM)
DE (2) DE69807239T2 (OSRAM)
DK (2) DK1014993T3 (OSRAM)
EE (1) EE04297B1 (OSRAM)
ES (2) ES2182357T3 (OSRAM)
HK (1) HK1045812B (OSRAM)
HU (1) HUP0003848A2 (OSRAM)
ID (1) ID24838A (OSRAM)
IL (1) IL134773A (OSRAM)
IN (1) IN190791B (OSRAM)
IS (1) IS2715B (OSRAM)
MX (1) MXPA00002615A (OSRAM)
MY (1) MY127812A (OSRAM)
NO (1) NO327176B1 (OSRAM)
NZ (1) NZ503173A (OSRAM)
PL (1) PL190782B1 (OSRAM)
PT (2) PT1210943E (OSRAM)
RU (1) RU2199322C2 (OSRAM)
SA (1) SA98190773B1 (OSRAM)
SE (1) SE9703407D0 (OSRAM)
SI (2) SI1210943T1 (OSRAM)
SK (1) SK285330B6 (OSRAM)
TR (1) TR200000726T2 (OSRAM)
TW (1) TW546140B (OSRAM)
UA (1) UA72446C2 (OSRAM)
WO (1) WO1999015182A1 (OSRAM)
ZA (1) ZA988516B (OSRAM)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
PL200941B1 (pl) * 1998-11-13 2009-02-27 Jagotec Ag Suchy proszkowy preparat inhalacyjny
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
GB9928311D0 (en) 1999-11-30 2000-01-26 Novartis Ag Organic compounds
GB0009584D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
GB0012261D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
GB0012260D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
JP5154732B2 (ja) * 2001-02-06 2013-02-27 イノバータ・バイオメッド・リミテッド 薬剤
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
SE0200312D0 (sv) 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
KR20050056222A (ko) * 2002-09-30 2005-06-14 아쿠스피어 인코포레이티드 흡입용 지속 방출형 다공성 미세입자
US20040121003A1 (en) * 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
US6962006B2 (en) * 2002-12-19 2005-11-08 Acusphere, Inc. Methods and apparatus for making particles using spray dryer and in-line jet mill
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
EP2397034A1 (en) * 2005-07-14 2011-12-21 Lithera, Inc. Sustained Release Enhanced Lipolytic Formulation for Regional Adipose Tissue Treatment
US20070148211A1 (en) * 2005-12-15 2007-06-28 Acusphere, Inc. Processes for making particle-based pharmaceutical formulations for oral administration
US7913223B2 (en) * 2005-12-16 2011-03-22 Dialogic Corporation Method and system for development and use of a user-interface for operations, administration, maintenance and provisioning of a telecommunications system
GB0604141D0 (en) * 2006-03-01 2006-04-12 Arrow Int Ltd Nebulizer formulation
ES2398480T3 (es) * 2006-10-17 2013-03-19 Lithera, Inc. Procedimientos, composiciones, y formulaciones para el tratamiento de la enfermedad ocular tiroidea
US9132084B2 (en) * 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
AR076807A1 (es) 2009-05-29 2011-07-06 Pearl Therapeutics Inc Composiciones metodos y sistemas para el suministro de dos o mas agentes activos mediante las vias respiratorias. metodo de preparacion composicion
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
US20110132355A1 (en) * 2009-06-09 2011-06-09 William Gerhart Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration
CN102000090A (zh) * 2009-08-31 2011-04-06 北京利乐生制药科技有限公司 一种以布地奈德与阿福特罗为活性成分的复方制剂
BR112012017556A2 (pt) * 2010-01-15 2016-08-16 Lithera Inc formulações de torta liofilizada
GEP201606551B (en) 2010-11-24 2016-10-10 Novamedica Llc Selective, lipophilic, and long-acting beta agonists monotherapeutic formulations tions and methods for cosmetic treatment of adiposity and contour bulging
US9585930B2 (en) 2011-03-20 2017-03-07 Trustees Of Boston University Therapeutic agent for emphysema and COPD
CN102362860A (zh) * 2011-10-27 2012-02-29 江阴长风医药科技有限公司 以氢氟烷烃为抛射剂的布地奈德和福莫特罗气雾剂制剂
CA2905542C (en) 2013-03-15 2022-05-03 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
ITMI20130571A1 (it) * 2013-04-10 2014-10-11 Zambon Spa Composizione farmaceutica contenente budesonide e formoterolo
WO2015065220A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения
GB201321712D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Dry Powder Inhaler
GB201321717D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
GB201408387D0 (en) * 2014-05-12 2014-06-25 Teva Pharmaceuticals Europ B V Treatment of respiratory disorders
EP3383366B2 (en) 2015-12-04 2024-06-05 Mexichem Fluor S.A. de C.V. Pharmaceutical composition
EP3807889A1 (en) 2018-06-14 2021-04-21 AstraZeneca UK Limited Methods for treating and preventing symptoms of asthma with a corticosteroid pharmaceutical composition
WO2021048171A1 (en) * 2019-09-10 2021-03-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Method to improve phagocytosis
WO2021076701A1 (en) 2019-10-17 2021-04-22 Trustees Of Boston University Methods and compositions relating to lung function

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3042866B2 (ja) 1989-09-08 2000-05-22 グラクソ・グループ・リミテッド 呼吸疾患治療薬
IL95590A (en) 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
US5250286A (en) * 1990-05-07 1993-10-05 Aegis Technology, Inc. Treatment of chronic obstructive pulmonary disease (COPD) by inhalation of an imidazoline
PL164294B1 (pl) 1990-12-20 1994-07-29 Inst Farmaceutyczny Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5444521A (en) 1991-07-15 1995-08-22 Canon Kabushiki Kaisha Image fixing device capable of controlling heating overshoot
AU673660C (en) * 1991-12-18 2002-07-25 Astrazeneca Ab New combination of formoterol and budesonide
EP1101493A3 (en) 1991-12-18 2004-01-14 AstraZeneca AB New combination of formoterol and budesonide
SE9404080L (sv) * 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
SE9700134D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
US5983956A (en) * 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
GB9519692D0 (en) 1995-09-27 1995-11-29 Quillin Helen Atomising nozzle
CA2238298A1 (en) * 1995-11-24 1997-06-19 Luca Francesco Raveglia Quinoline derivatives
SE9603669D0 (sv) 1996-10-08 1996-10-08 Astra Ab New combination
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
JP2002510310A (ja) 1997-06-27 2002-04-02 アストラ・アクチエボラーグ 抗喘息薬の新規配合
SE9703407D0 (sv) * 1997-09-19 1997-09-19 Astra Ab New use
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6004537A (en) 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
SE9900834D0 (sv) 1999-03-09 1999-03-09 Astra Ab Novel combination

Also Published As

Publication number Publication date
PL339295A1 (en) 2000-12-04
SE9703407D0 (sv) 1997-09-19
DK1014993T3 (da) 2002-11-11
BR9812325A (pt) 2000-09-05
JP2001517630A (ja) 2001-10-09
SI1014993T1 (en) 2003-02-28
CY1106156T1 (el) 2011-06-08
US20020042404A1 (en) 2002-04-11
EE200000145A (et) 2001-02-15
ES2182357T3 (es) 2003-03-01
EP1014993A1 (en) 2000-07-05
CN1149998C (zh) 2004-05-19
ID24838A (id) 2000-08-24
AU9192898A (en) 1999-04-12
US20110097282A1 (en) 2011-04-28
MY127812A (en) 2006-12-29
DE69807239D1 (de) 2002-09-19
KR20010024140A (ko) 2001-03-26
RU2199322C2 (ru) 2003-02-27
MXPA00002615A (es) 2002-04-24
AR013506A1 (es) 2000-12-27
IN190791B (OSRAM) 2003-08-23
HK1045812A1 (en) 2002-12-13
IL134773A0 (en) 2001-04-30
WO1999015182A1 (en) 1999-04-01
CA2302700A1 (en) 1999-04-01
TW546140B (en) 2003-08-11
IL134773A (en) 2005-03-20
DE69834955D1 (de) 2006-07-27
SK3892000A3 (en) 2000-12-11
CZ2000950A3 (cs) 2000-06-14
ATE329599T1 (de) 2006-07-15
AU757235B2 (en) 2003-02-06
ES2266322T3 (es) 2007-03-01
US8461211B2 (en) 2013-06-11
ZA988516B (en) 1999-03-19
DK1210943T3 (da) 2006-09-18
NO327176B1 (no) 2009-05-04
PT1014993E (pt) 2002-12-31
DE69834955T2 (de) 2007-01-25
HUP0003848A2 (hu) 2001-08-28
NO20001401D0 (no) 2000-03-17
EE04297B1 (et) 2004-06-15
HK1045812B (en) 2006-12-22
NZ503173A (en) 2001-08-31
PL190782B1 (pl) 2006-01-31
SA98190773B1 (ar) 2006-10-02
IS5407A (is) 2000-03-15
US20060189587A9 (en) 2006-08-24
ATE222106T1 (de) 2002-08-15
EP1210943B1 (en) 2006-06-14
UA72446C2 (uk) 2005-03-15
EP1210943A1 (en) 2002-06-05
EP1014993B1 (en) 2002-08-14
SI1210943T1 (sl) 2006-10-31
TR200000726T2 (tr) 2000-09-21
NO20001401L (no) 2000-03-17
CA2302700C (en) 2010-11-23
IS2715B (is) 2011-02-15
CN1271287A (zh) 2000-10-25
US7897646B2 (en) 2011-03-01
SK285330B6 (sk) 2006-11-03
CZ295250B6 (cs) 2005-06-15
DE69807239T2 (de) 2003-04-10

Similar Documents

Publication Publication Date Title
PT1210943E (pt) Nova utilizacao para budesonida e formoterol
ATE201138T1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung und prophylaxe der multiplen sclerose
FI970920L (fi) Trifenyylietyleenejä käytettäväksi osteoporoosin ehkäisyyn ja hoitoon
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
ID27937A (id) Penggunaan komposisi yang mengandung formoterol dan budesonida untuk pencegahan atau pengobatan kondisi asma yang akut
FI971412A7 (fi) Peptididyyliyhdisteet ja niiden terapeuttinen käyttö metalloproteaasie n estäjinä
BR9711530A (pt) Combina-Æo de terapia para tratamento de psicoses
FI964314A7 (fi) Substituoidut sulfonamidit selektiivisinä beta3-agonisteina diabeteksen ja liikalihavuuden hoitoon
ATE179610T1 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
DE69525107D1 (de) Gasmischeinrichtungen für Wiederbelebungs- und Beatmungsvorrichtungen
FI972781L (fi) Menetelmät ja koostumukset allergisen nuhan ja muiden sairauksien hoitamiseksi käyttäen dekarboetokyloratadieeniä
BR9407869A (pt) Combinaçao composiçao farmacêutica e processo para o tratamento de osteoporose
FI971151A7 (fi) Kolesterolin absorption inhibiittorin ja kolesterolin synteesin inhibi ittorin yhdistelmä
DE69518559D1 (de) Verfahren zur Zuteilung und zum Planen von Betriebsmitteln
DE69838728D1 (de) Methoden und zusammensetzungen zum wirksameren abfangen von sauerstoff
BR9814040A (pt) Agudo no pulmão com fibrose com antagonistas de avb6
BR8401148A (pt) Composicao descorante para limpeza do corpo e metodo de limpar e desodorizar simultaneamente o corpo
ID18679A (id) Penggunaan terapi lanjutan
FI971750A0 (fi) Koostumuksia multippeliskleroosia varten ja sen hoito
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE69519602D1 (de) Kugelförmige Aktivkohle zur Behandlung von Hämorrhoiden
BR9510554A (pt) Uso de moléculas de ligação de mch-ii e/ou moléculas de imitação para a prevenção e/ou tratamento de doenças inflamatórias
FI963264A7 (fi) Tromboksaani A2-välitteisten sairauksien ennaltaestoon ja hoitoon tarkoitettu aine
DE69418931D1 (de) Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten
IS5534A (is) Ný notkun staðdeyfandi efna gegn æðahöfuðverkjum